Schaafheim, Germany

Michel Mühlig

This inventor holds 1 USPTO granted patent. Top assignee: Alcon, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Mühlig. Retrieved from https://idiyas.com/inventor/michel-mühlig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Mühlig: Innovator in Ophthalmic Technology

Introduction

Michel Mühlig is a notable inventor based in Schaafheim, Germany. He has made significant contributions to the field of ophthalmic technology, particularly through his innovative designs and systems.

Latest Patents

Michel holds a patent for a gripper system designed for an ophthalmic lens. This invention showcases his expertise in creating practical solutions for the medical field, enhancing the efficiency and effectiveness of ophthalmic procedures. He has 1 patent to his name.

Career Highlights

Michel Mühlig is currently employed at Alcon, Inc., a leading company in eye care products. His work at Alcon has allowed him to focus on developing advanced technologies that improve patient outcomes in ophthalmology.

Collaborations

Throughout his career, Michel has collaborated with various professionals in the field. One of his notable coworkers is Johannes Neumann, with whom he has worked on innovative projects that push the boundaries of ophthalmic technology.

Conclusion

Michel Mühlig's contributions to ophthalmic technology through his patent and work at Alcon, Inc. highlight his role as an influential inventor in the medical field. His dedication to innovation continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…